Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression

BACKGROUND: According to the amyloid, tau, neurodegeneration research framework classification, amyloid and tau positive (A+T+) mild cognitive impairment (MCI) individuals are defined as prodromal Alzheimer disease. This study was designed to compare the clinical and biomarker features between A+T+M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Hong-Chun, Li, Bing, Ng, Kok Pin, Fu, Qing-Xi, Dong, Sheng-Jie, Ba, Mao-Wen, Kong, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318651/
https://www.ncbi.nlm.nih.gov/pubmed/34397597
http://dx.doi.org/10.1097/CM9.0000000000001496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318651/
https://www.ncbi.nlm.nih.gov/pubmed/34397597
http://dx.doi.org/10.1097/CM9.0000000000001496

Ejemplares similares